AARON I. VINIK, M.B., B.Ch., M.D.; NORMAN THOMPSON, M.D.
This content is PDF only. Please click on the PDF icon to access.
The Zollinger-Ellison syndrome is characterized by persistent basal gastric acid hypersecretion due to hypergastrinemia. Death from fulminant ulcer disease is now rarely seen, and death from progression of the tumor has become the major issue. Management of nearly all patients with this disease was previously by total gastrectomy, and no attempt was made to identify or remove the source of gastrin hypersecretion. Over the 3 decades since the syndrome's description, there has been much debate as to the optimal form of management (1-3). Controversial areas include definition of subvarieties of the syndrome, each of which requires a different approach to
VINIK AI, THOMPSON N. Controversies in the Management of ZollingerEllison Syndrome. Ann Intern Med. ;105:956–959. doi: 10.7326/0003-4819-105-6-956
Download citation file:
Published: Ann Intern Med. 1986;105(6):956-959.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use